From: Prediction of health care expenditure increase: how does pharmacotherapy contribute?
Contribution to prediction of increase | |||||
ATC | Name | Acc,% | N | ||
N06DA | Anticholinesterases | 77.3 | 88 | ||
A12CC | Magnesium | 71.4 | 56 | ||
B03BB | Folic acid and derivatives | 69.1 | 408 | ||
A10AE | Insulins and analogues for injection, long-acting | 68.1 | 91 | ||
B01AA | Vitamin K antagonists | 67.3 | 1065 | ||
A03FA | Propulsives | 65.5 | 58 | ||
Contribution to prediction of decrease | |||||
Without Hospitalisation | With Hospitalisation | ||||
ATC | Name | Acc,% | N | Acc,% | N |
A12CC | Magnesium | 78.6 | 28 | 78.8 | 33 |
B01AC | Platelet aggregation inhibitors excluding heparin | 76.9 | 26 | 82.9 | 345 |
C01BD | Antiarrhythmics, class III | 73.3 | 30 | 81.0 | 58 |
N06CA | Antidepressants in combination with psycholeptics | 69.5 | 59 | 75.0 | 44 |
B01AA | Vitamin K antagonists | 68.8 | 173 | 74.5 | 471 |
A03FA | Propulsives | 65.8 | 146 | 84.6 | 143 |